Dr. Thébaud and his team have been awarded a prestigious 7-year Foundation Scheme grant from the Canadian Institutes of Health Research (CIHR) valued at $3.2 million to support the development of three different kinds of stem cell treatments for babies with life-threatening lung diseases. His team is one of seven at The Ottawa Hospital awarded a CIHR Foundation Scheme Grant.
